Many people report fewer intrusive food thoughts, less urgency around snacking, and improved control in situations that previously triggered overeating. That can ease emotional or stress-linked eating because the immediate pull of ultra-palatable foods is quieter. Wegovy isn’t a treatment for mental-health conditions, so ongoing support — sleep, stress tools, counselling if needed — remains important. If mood changes occur, tell your clinical team so they can review and suppo

Wegovy isn’t licensed in the UK to treat fatty liver or other conditions directly, but weight reduction can improve liver fat and broader...

Many people report fewer intrusive food thoughts, less urgency around snacking, and improved control in situations that previously...

Storage is straightforward: keep pens in the refrigerator in their original carton, and do not freeze. Protect from light and check the...

Storage is straightforward: keep pens in the refrigerator in their original carton, and do not freeze. Protect from light and check the...

Wegovy acts directly on GLP-1 receptors; effects on ghrelin and leptin are indirect and vary between individuals. By strengthening...

Wegovy acts directly on GLP-1 receptors; effects on ghrelin and leptin are indirect and vary between individuals. By strengthening...

Wegovy is a once-weekly subcutaneous injection given into the abdomen, thigh, or upper arm. Rotate sites each week and avoid areas that...

The duration is guided by your response, tolerability, and local commissioning policy. Services typically build in review points — for...

The duration is guided by your response, tolerability, and local commissioning policy. Services typically build in review points — for example, at six months and at later milestones — to check progress and decide on continuation. Some pathways set a maximum course length; others allow ongoing use if agreed benchmarks are met within specialist care. Your team will set expectations clearly at the start so you know how and when decisions will be made. Why duration is not the sam

Wegovy is a once-weekly subcutaneous injection given into the abdomen, thigh, or upper arm. Rotate sites each week and avoid areas that...

Suitability depends on your health profile, but many people with common conditions like type 2 diabetes or high blood pressure can use...

Suitability depends on your health profile, but many people with common conditions like type 2 diabetes or high blood pressure can use Wegovy within specialist care. If you take insulin or medicines that can cause low blood sugar, your prescriber may adjust doses to reduce hypo risk as appetite changes. Blood-pressure tablets usually continue as normal, with routine monitoring as weight and salt intake shift. People with a history of certain rare endocrine or pancreatic issue

For long-term weight loss, sustained treatment in structured services has shown meaningful average reductions, with plateaus that are...

For long-term weight loss, sustained treatment in structured services has shown meaningful average reductions, with plateaus that are...

Some people notice appetite changes within the first few weeks, but the medicine is introduced gradually to improve tolerability, so its...

The dosage schedule is once weekly on the same day, using a step-up “titration” plan to reach a maintenance dose. A common pathway starts...

The dosage schedule is once weekly on the same day, using a step-up “titration” plan to reach a maintenance dose. A common pathway starts low (for example, 0.25 mg weekly) and increases in stages (0.5 mg → 1.0 mg → 1.7 mg) toward a usual maintenance dose of 2.4 mg weekly, with each step typically lasting several weeks. If side effects occur, clinicians can extend a step or pause before moving up; this flexibility is standard practice across UK services. People scheduled for p

Some people notice appetite changes within the first few weeks, but the medicine is introduced gradually to improve tolerability, so its...

Compared with other weight-loss medications available in the UK, Wegovy relies on GLP-1 receptor activation to lower appetite, while...